Burkholderia cenocepacia ZmpA is expressed as a preproenzyme typical of thermolysin-like proteases such as Pseudomonas aeruginosa LasB and Bacillus thermoproteolyticus thermolysin. The zmpA gene was expressed using the pPRO-EXHTa His 6 tag expression system, which incorporates a six-His tag at the N-terminal end of the protein, and recombinant ZmpA was purified using Ni-nitrilotriacetic acid affinity chromatography. Upon refolding of the recombinant His 6 -pre-pro-ZmpA (62 kDa), the fusion protein was autoproteolytically cleaved into 36-kDa (mature ZmpA) and 27-kDa peptides. Site-directed mutagenesis was employed to infer the identity of the active site residues of ZmpA and to confirm that the enzyme undergoes autoproteolytic cleavage. Oligonucleotide mutagenesis was used to replace H 465 with G 465 or A 465 , E 377 with A 377 or D 377 , or H 380 with P 380 or A 380 . Mutagenesis of H 465 , E 377 , or H 380 resulted in the loss of both autocatalytic activity and proteolytic activity. ZmpA with either substitution in H 380 was not detectable in B. cenocepacia cell extracts. The activity of the recombinant ZmpA was inhibited by EDTA and 1,10 phenanthroline, indicating that it is a zinc metalloprotease. ZmpA, however, was not inhibited by phosphoramidon, a classical inhibitor of the thermolysin-like proteases. The refolded mature ZmpA enzyme was proteolytically active against various substrates including hide powder azure, type IV collagen, fibronectin, neutrophil ␣-1 proteinase inhibitor, ␣ 2 -macroglobulin, and gamma interferon, suggesting that B. cenocepacia ZmpA may cause direct tissue damage to the host or damage to host tissues through a modulation of the host's immune system.
phonuclear leukocyte infiltration and proteinaceous exudate in the airways (34) . Using a rat agar bead model of infection, a B. cenocepacia K56-2 zmpA mutant elicited significantly less lung damage than the wild-type strain (10) . In most cases, the B. cenocepacia K56-2 zmpA mutant was cleared from the rat lungs, indicating that ZmpA is required for the persistence of B. cenocepacia K56-2. Neutralizing monoclonal antibodies (MAbs) raised against ZmpA cross-react with a Pseudomonas aeruginosa LasB epitope (25, 26) . Immunization with a peptide ( 341 HGFTEQNG 349 ) corresponding to this conserved P. aeruginosa LasB epitope significantly decreases the severity of experimental B. cenocepacia lung infections (48) . Although there is evidence from animal infection models that ZmpA plays a major role in the virulence of B. cenocepacia, the direct role of ZmpA in B. cenocepacia pathogenesis is not understood.
Bacterial proteases may exert tissue damage directly by cleaving cellular components such as elastin, collagen, or fibronectin (1, 30, 36) . They may also cause tissue damage by affecting the balance between neutrophil elastase and the inhibitors ␣ 1 -proteinase inhibitor and ␣ 2 -macroglobulin. The balance between proteases and protease inhibitors may be the major factor in determining tissue integrity. P. aeruginosa LasB has been shown to cleave ␣ 1 -proteinase inhibitor (39) . The importance of this neutrophil elastase/inhibitor balance is demonstrated by the finding that ␣ 1 -proteinase deficiency is associated with pulmonary emphysema. Bacterial proteases may also exert their effect by cleaving components of the immune system, including immunoglobulins (Ig), complement components, and cytokines such as gamma interferon (IFN-␥), and tumor necrosis factor alpha (reviewed in reference 28). P. aeruginosa LasB has been shown to degrade lactoferrin and transferrin (5) . This may make more iron available for bacte-rial growth or promote oxidant-mediated damage to host tissues.
Many bacterial zinc metalloproteases have been classified as either clan MA or clan MB (43) . B. cenocepacia ZmpA appears to belong to family M4 of the MA clan (10) . Family M4, also referred to as the thermolysin-like proteases, contains only bacterial metalloproteases. Bacillus thermoproteolyticus thermolysin was the first zinc metalloprotease for which the threedimensional structure was determined (9) . Typically the thermolysin-like metalloproteases contain the HExxH and GAxNEAFSD motifs and have a neutral pH optimum (43) . The thermolysin-like metalloproteases usually have specificity for hydrophobic amino acid residues and are inhibited by the zinc metalloprotease inhibitors EDTA, 1,10 phenanthroline, and phosphoramidon (43) . ZmpA shares homology with preproenzymes (10) , including the thermolysin-like proteases P. aeruginosa LasB, B. thermoproteolyticus thermolysin, and Vibrio cholerae hemagglutinin/protease (2, 16, 42) . ZmpA has the conserved HExxH and GAxNEAFSD motifs that are found in the M4 family of proteases (10, 43) . The two histidine residues in the 375HExxH380 motif and the glutamic acid in the GAxNEAFSD motif putatively act as the zinc ligands. A water molecule typically provides the fourth zinc ligand. The glutamic acid in the HExxH active site motif and a histidine further downstream are putatively required for proteolytic activity.
In this study, zmpA was expressed in Escherichia coli and the recombinant ZmpA protease was purified and characterized. Putative active site residues and a putative zinc ligand residue were mutagenized, and the effects of these mutations on the autocatalytic and proteolytic activity of ZmpA were determined. The substrate specificities of both native and recombinant ZmpA were also compared.
MATERIALS AND METHODS
Bacterial strains, plasmids, and reagents. The bacterial strains and plasmids used in this study are described in Table 1 . B. cenocepacia strains were grown on tryptic soy agar or B. cepacia selective agar (18) with 200 g/ml tetracycline (Tc) or 100 g/ml trimethoprim (Tp) where required. E. coli DH5␣ was grown in Luria-Bertani broth with 100 g/ml ampicillin (Ap) and/or 12.5 g/ml Tc where required. Restriction enzymes and oligonucleotide primers were purchased from Invitrogen (Burlington, Ontario, Canada). T4 DNA ligase, T4 polymerase, and the pAlter mutagenesis kit were purchased from Promega. DNA sequencing was performed at Macrogen Inc. (South Korea). All chemicals were purchased from Sigma-Aldrich except where indicated. Expression and solubilization of recombinant forms of ZmpA. A 1.7-kb fragment containing the zmpA gene was amplified by PCR from pCC12 (10) with the primers NPPEXF (GAATTCATGAAGAAACTGTCTCG) containing an EcoRI linker (underlined) and NPEXR (AAGCTTTCAATTCACCCCG) containing a HindIII linker (underlined). The resultant product was cloned into pCR2.1-TOPO (Invitrogen) and subcloned into pPROEX-Hta (Invitrogen) at the EcoRI and HindIII sites, resulting in pCK10 (Table 1) . Genetic manipulations were generally performed as described by Sambrook et al. (45) .
E. coli DH5␣ pC⌲10 subcultures were induced with 0.6 mM isopropyl-␤-Dthiogalactopyranoside (IPTG) at an optical density at 600 nm (OD 600 ) of approximately 0.4. The optimum incubation time was determined by removing 1 ml of the culture at 1, 2, 3, and 4 h after induction and analyzing the normalized samples by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE), after which cultures were typically harvested after 3.5 h of induction. Cultures were centrifuged at 8,000 ϫ g for 20 min. Pellets were resuspended in 10 ml sonication buffer (SB; 50 mM sodium phosphate, pH 8.0, 300 mM NaCl), sonicated for 5 15-s bursts and centrifuged at 15,000 ϫ g to determine if the expressed ZmpA was soluble or insoluble. The insoluble pellets were washed stepwise with SB and 2 M sodium chloride, SB and 0.25% Triton X-100, and SB and 2 M sodium chloride. The samples were centrifuged at 6,000 ϫ g between washes. The final pellets were resuspended in SB with 6 M guanidine hydrochloride.
The gene coding for the mature ZmpA protein (bp 655 to 1695; numbering is based on the entire preprozmpA gene) was amplified by PCR with the primers NPEXF (GAATTCGCCGCCGCGACCG) containing an EcoRI linker (underlined) and NPEXR (AAGCTTTCAATTCACCCCG) containing a HindIII linker (underlined). This fragment with an additional 27 bases (bp 628 to 1695) at the 5Ј end was amplified by PCR using the primers NPEXF2 (GAATTCCT CGATGCACAGGACC) containing an EcoRI linker (underlined) and NPEXR (AAGCTTTCAATTCACCCCG) containing a HindIII linker (underlined) and cloned as above, resulting in plasmid pCK15. Native ZmpA was purified from culture supernatants as previously described (34) .
Refolding of recombinant mature ZmpA and preproZmpA. The solubilized mature ZmpA or preproZmpA was bound to Ni-nitrilotriacetic acid (NTA) (QIAGEN), which had been preequilibrated in SB, containing 6 M guanidine hydrochloride, for at least 1 h at 4°C. The bound ZmpA was washed with 5 column volumes (CV) of 20 mM Tris-HCl, pH 7.4, 6 M guanidine hydrochloride (buffer A), and 5 CV 50 mM Tris-HCl, pH 7.4, 20% glycerol, 500 mM sodium chloride, and 6 M urea (buffer B), followed by 50 CV buffer B to 50 mM Tris-HCl, pH 7.4, 20% glycerol, 500 mM sodium chloride, 1 M urea (buffer C) linear gradient. The bound ZmpA was washed with 5 CV buffer C, 5 CV 50 mM Tris-HCl, pH 7.4, 10% glycerol, 50 mM NaCl (buffer D), and 5 CV SB. The refolded ZmpA was eluted from the Ni-NTA with 100 mM imidazole. The eluted ZmpA was typically dialyzed against 10 mM Tris-HCl, pH 7.2, prior to proteolytic analysis of the enzyme. Proteolytic activity was determined using 7.5 mg hide powder azure (Sigma-Aldrich) in 1.5 ml 10 mM Tris-HCl (43) . One unit of activity was defined as the amount of protease required to cause a change in the OD 595 of 0.1 in 1 h (43) .
SDS-PAGE and Western immunoblot analysis of ZmpA. Proteins were separated by SDS-12.5% (except where indicated) PAGE by the method of Laemmli (27) . The gels were stained using Coomassie brilliant blue R-250 or transferred to polyvinylidene difluoride membrane (Millipore) (51) . Immunoblots were reacted with either MAb 36-6-6 (25) to ZmpA or mouse anti-His tag antibody (GE Healthcare).
N-terminal amino acid sequencing of the recombinant ZmpA. Partial Nterminal amino acid sequencing was performed on polyvinylidene difluorideelectroblotted proteins at the University of Victoria (UVic-Genome BC Proteomics Center) or at the University of British Columbia (NAPS unit, Protein Microchemistry).
Mutagenesis of zmpA. A 2.6-kb PstI fragment containing the zmpA gene was subcloned into the pAlter-EX1 vector (Promega), resulting in the vector pCK20. Mutagenic oligonucleotides were designed to change H 465 to G 465 (ZmpA H465G), E 377 to A 377 (ZmpA E377A), and H 380 to P 380 (ZmpA H380P). The primers employed were NPH465G, CCGCGCCACGATCCCGGGTTCACGT CGGG; NPE377A, GTCGCCGGGCATGCGATGAGCCACGGC; and NPH380P, CGAGATGAGCCCCGGGGTGACCGAGGCC. These oligonucleotides were designed to introduce a restriction site (underlined; SmaI, SphI, and SmaI, respectively) for use in subsequent screening. Mutagenic oligonucleotide pairs (CCGCGCCACGATCCGGCTTTCACGTCGGGGGTC and GACCCCC GACGTGAAAGCCGGATCGTGGCGCGG; GACGTCGCCGGGCACGAC ATGAGCCACGGCGTG and CACGCCGTGGCTCATGTCGTGCCCGGCG ACGTC; and GGGCACGAGATGAGCGCCGGCGTGACCGAGGCC and GGCCTCGGTCACGCCGGCGCTCATCTCGTGCCC) were designed to change H 465 to A 465 (ZmpA H465A), E 377 to D 377 (ZmpA E377D), and H 380 to A 380 (ZmpA H380A) in pCK10, respectively, using the QuikChange system (Stratagene).
Mutagenesis was conducted and transformants were screened by PCR with the primers NPPEXF and NPEXR, to ensure that an intact zmpA gene was present. Mutations were confirmed by sequence analysis. Recombinant zmpA genes were PCR amplified with the NPPEXF and NPEXR primers, cloned into pCR2.1-TOPO, excised with EcoRI and HindIII, and ligated into the corresponding sites in pPROEX-Hta. Expression, solubilization, purification, and characterization of the ZmpA mutant proteins were performed as described above.
Complementation of the zmpA deletion mutant K56-2-9. To determine if ZmpA H465G, ZmpA H465A, ZmpA E377A, ZmpA E377D, ZmpA H380P, and ZmpA H380A had proteolytic activity in B. cenocepacia, SunI-HindIII fragments encompassing the mutated sites from the wild-type (pCK10) or mutant plasmids (pCK11-pCK13b) were cloned into the SunI/HindIII site in pCC12. PstI-HindIII fragments from the resulting constructs containing the zmpA gene with 642 bp of upstream DNA were subsequently cloned into pUCP26, resulting in pCK40 (ZmpA) and plasmids containing mutant zmpA genes (pCK41-pCK43b; Table 1 ). These constructs were electroporated into B. cenocepacia K56-2-9 as previously described (12) . Protease activity was determined on dialyzed brain heart infusion milk agar as previously described (49) . Accumulation of the wild-type and mutant ZmpA proteins was determined in cell lysates by Western immunoblotting of SDS-PAGE reacted with rat anti-ZmpA serum.
Protease inhibitor profile of the recombinant ZmpA. Recombinant ZmpA and native ZmpA (4.0 units) in a volume of 1 ml of 10 mM Tris-Cl, pH 7.2, were incubated with either 1 mM 1,10 phenanthroline, 10 mM EDTA, 10 M phosphoramidon, 50 M 4-(amidinophenyl)methanesulfonyl fluoride (APMSF), 0.5 mM phenylmethanesulfonyl fluoride (PMSF), 0.1 mM di-isopropylfluorophosphate (DFP), 5 M L-trans-epoxysuccinyl-leucylamide-(4-guanidino)-butane (E-64), or 1 M pepstatin A for 30 min at 37°C. Native and recombinant ZmpA reactions without inhibitor were included as controls. For the phosphoramidon inhibition experiments, P. aeruginosa LasB (10 ng) (Nagase) and B. thermoproteolyticus thermolysin (50 ng) were included as additional controls. The proteolytic activity of the reaction mixtures was measured using the hide powder azure assay. Neutralization by MAb 36-6-6 was tested as previously described (25) .
Substrate analysis of the recombinant ZmpA. Approximately 50 ng native and recombinant ZmpA was incubated with hide powder azure or azocasein in Tris-HCl, pH 7.2, 1 mM CaCl 2 , and 1 mM MgSO 4 for 2 and 24 h, respectively. After the incubation, the samples were centrifuged for 10 min at 10,000 ϫ g and the ODs at 595 nm and 440 nm, respectively, were measured. One unit of activity was defined as the amount of protease required to cause a change in the OD 595 of 0.1 per hour at 37°C in the hide powder azure assay. For the analysis of subsequent substrate digestions, 6.0 units of native and recombinant ZmpA activity was used in each assay.
To optimize the substrate digestions by ZmpA, various buffers were tested at a range of pHs in hide blue azure assays, as described above (44) . Buffers tested were 25 mM morpholinoethanesulfonic acid, pH 5.6 to 6.7 (MES), 25 mM sodium succinate, pH 4.0 to 5.6, sodium acetate, pH 4.0 to 5.3, 25 mM sodium citrate, pH 3.5 to 6.0, 25 mM piperazine-1,4-bis(2-ethanesulfonic acid) (PIPES), pH 6.5 to 7.2, 25 mM 3-(N-morpholino)propanesulfonic acid (MOPS), pH 6.5 to 7.5, 25 mM Tris-maleate, pH 5.2 to 6.0, and 25 mM Tris-HCl, pH 7.0 to 9.0.
Native and recombinant ZmpA (6 U) was incubated for 24 to 48 h at 37°C with ␣-1 proteinase inhibitor (Bayer), human fibronectin, type IV collagen, lactoferrin, transferrin, immunoglobulins A, G, and M, rat ␣ 2 -macroglobulin, and recombinant rat gamma interferon (Sigma) in 25 mM MES, pH 6.5. Native ZmpA, recombinant ZmpA, and substrate only controls were included. In some experiments, P. aeruginosa LasB was included as a positive control for substrate digestions. Digested substrates were separated by SDS-12.5% PAGE by the method of Laemmli (27) or by Tricine-SDS-16% PAGE (46) .
RESULTS
Expression and purification of the recombinant mature and preproZmpA. Attempts to amplify the region corresponding to the mature protein (bp 655 to 1695) were unsuccessful. This is probably due to the high GC content of the DNA encoding the N terminus of the mature ZmpA protein. Thus, a DNA fragment encoding the mature ZmpA with nine additional amino acids at the N terminus was amplified and cloned into the pPROEX-HTa His 6 tag expression system. Expression of a 44-kDa protein with the predicted molecular mass was obtained after IPTG induction for 3 h (data not shown). This protein was solubilized in 6 M guanidine-HCl, refolded, and eluted from a Ni-NTA column. A single polypeptide with an approximate molecular mass of 44 kDa was eluted from the column, most likely corresponding to the fusion protein (His 6 nine amino acids [LDAQDLIKT]-mature ZmpA, data not shown). This polypeptide was proteolytically inactive, suggesting that it was improperly refolded (data not shown). This inactivity may also be due to the presence of an additional nine amino acids at the N terminus (from the pro region) or to the absence of a full-length pro sequence.
To determine if the prosequence is necessary for the correct folding and processing of ZmpA, the entire preproZmpA gene was expressed using the pPROEX-HTa His 6 tag expression system. The His preproZmpA was maximally expressed at 3 to 4 h post-IPTG induction as a 62-kDa protein (Fig. 1A) , which is the predicted molecular mass of this product. Following centrifugation of the cultures, the protease was not found in the cell culture supernatant but was located in the cell pellets (data not shown). Fractionation of E. coli cells demonstrated that the recombinant ZmpA was insoluble. The insoluble cell lysates containing ZmpA were washed with a series of salt and detergents with final solubilization in 50 mM sodium phosphate, pH 8.0, 300 mM NaCl, and 6 M guanidine hydrochloride. As shown in Fig. 1B , the recombinant His preproZmpA remained intact in the crude cell extract and in 6 M guanidine hydrochloride. When the protein was refolded on a Ni-NTA column using a 6 M to 1 M urea gradient followed by elution with 100 mM imidazole, the His preproZmpA was cleaved into two proteins with molecular masses of approximately 36 and 27 kDa (Fig. 1B) . Attempts to significantly increase the amount of autocatalysis by increasing temperature or by salt activation (22) were unsuccessful (data not shown). The 36-kDa cleavage product has the same M r as the native ZmpA ( Fig. 2A and B) . N-terminal amino acid sequencing was performed on the 36-and 27-kDa proteins. The sequence of the N terminus of the 36-kDa peptide was AAATG, which is identical to the N terminus of the mature ZmpA (10). The sequence of the N terminus of the 27-kDa peptide was SYYHHH, which corresponds to the vector sequence that precedes the pre sequence. The anti-His tag Ab reacted with both the 62-and 27-kDa peptides on Western blots but not with the 36-kDa peptide (Fig. 2C) . MAb 36-6-6 to ZmpA (25) reacted with the recombinant 62-kDa and 36-kDa proteins but not the 27-kDa protein, suggesting that the 62-kDa protein contains the 36-kDa mature enzyme (Fig. 2B) .
Mutational analysis of zmpA. Previous analysis of the deduced amino acid sequence of ZmpA revealed a zinc metalloprotease active site motif at amino acids 376-HExxH-380 (10) . A number of amino acids appear to be highly conserved with the thermolysin-like family, including E377, H380, and H465. These amino acids in P. aeruginosa LasB and B. thermoproteolyticus thermolysin are required for proteolytic activity with E377 and H465 involved in cleavage and H380 involved in binding zinc. To test whether these residues are required for ZmpA activity, E 377 was replaced with an alanine and aspartic acid, H 380 was replaced with a proline and alanine, and H 465 was replaced with a glycine and alanine. Wild-type preproZmpA, ZmpA H465G, ZmpA H465A, ZmpA E377A, ZmpA E377D, ZmpA H380P, and ZmpA H380A were expressed in E. coli and refolded using Ni-NTA chromatography. In the extracts from E. coli with the plasmids containing the mutant constructs, ZmpA H465G, ZmpA H465A, ZmpA E377A, ZmpA E377D, and ZmpA H380P, only the 62-kDa protein preproZmpA was detected, whereas the wild-type recombinant preproZmpA protein was processed into 36-kDa and 27-kDa polypeptides upon elution from the Ni-NTA column ( Fig. 2A) . These ZmpA mutant proteins displayed no proteolytic activity with the substrate hide powder azure.
To determine whether the mutant zmpA alleles are able to complement a B. cenocepacia zmpA mutant, these genes were introduced into K56-2-9 (10). The constructs pCK40, pCK41, pCK41b, pCK42, pCK42b, pCK43, and pCK43b express wildtype ZmpA, ZmpA H465G, ZmpA H465A, ZmpA E377A, ZmpA E377D, ZmpA H380P, and ZmpA H380A, respectively. Only pCK40 expressing wild-type ZmpA restored proteolytic activity in the zmpA mutant, K56-2-9 ( Table 2 ). H465 and E377 mutant ZmpA proteins were present in the cell extracts but were not processed into a mature form. H380 mutant ZmpA proteins were not detectable in cell extracts (Fig. 3) , suggesting that mutations at this site reduced the stability of ZmpA.
Characterization of the recombinant ZmpA. Several properties of the recombinant ZmpA were compared to those of native ZmpA isolated from culture supernatants. Both native ZmpA and the recombinant ZmpA were proteolytically active using hide powder azure as a substrate, although the native enzyme was slightly more active. Native ZmpA had 3.7 Ϯ 0.4 units activity per 50 ng protein compared to 1.9 Ϯ 0.1 units for recombinant ZmpA. Both native and recombinant ZmpA had poor activity against azocasein with OD 440 values of 0.054 Ϯ 0.001 and 0.006 Ϯ 0.007, respectively. In contrast, P. aeruginosa LasB (3 ng) had an OD 440 value of 1.508 Ϯ 0.011 against azocasein in this assay.
To confirm that ZmpA is a zinc metalloprotease, the effect of a number of protease inhibitors on the activity of the recombinant ZmpA was examined. The recombinant ZmpA had a protease inhibitor profile identical to that of the native (Table 3) . Proteolytic activity was inhibited by EDTA and 1,10 phenanthroline, indicating that ZmpA is a metalloprotease (Table 3 ). The serine, cysteine, or aspartic protease inhibitors did not inhibit ZmpA proteolytic activity. Neither the native nor recombinant ZmpA was inhibited by the specific thermolysin inhibitor, phosphoramidon, which did abrogate the proteolytic activity of both P. aeruginosa LasB and B. thermoproteolyticus thermolysin (Table 4) . MAb 36-6-6 has previously been shown to neutralize native ZmpA activity (25) . Using hide powder azure as the substrate, MAb 36-6-6 completely neutralized the proteolytic activity of both native (OD 595 0.0 Ϯ 0.001) and recombinant ZmpA (OD 595 0.02 Ϯ 0.01) compared to the effect of control ascites on native ZmpA (OD 595 0.46 Ϯ 0.09) and recombinant ZmpA (OD 595 0.38 Ϯ 0.01). Previously, native ZmpA has been shown to digest gelatin and collagen (34) . To determine if ZmpA has a broader range of substrates, digestion of various substrates with the recombinant and native ZmpA was tested. Both native and recombinant ZmpA cleaved ␣-1 proteinase inhibitor resulting in a 49-kDa polypeptide (Fig. 4A) . The partial N-terminal amino acid sequence of this 49-kDa peptide is DTSHHDQD. ZmpA specifically cleaved ␣ 2 -macroglobulin into 95-and 86-kDa products (Fig. 4B) . Both native and recombinant ZmpA digested type IV collagen, human fibronectin (Fig. 4C) , and gamma interferon (Fig. 4D) . In order to ensure that this cleavage was not due to the presence of a contaminating E. coli protease, these substrates were digested with a recombinant mutant ZmpA that was purified in parallel with the recombinant wild-type ZmpA. ZmpA H465G did not cleave ␣-1 proteinase inhibitor, ␣ 2 -macroglobulin, type IV collagen, human fibronectin, or gamma interferon (data not shown).
Recombinant wild-type ZmpA did not digest human lactoferrin, transferrin, IgA, IgG, and IgM under the conditions employed in this study (Fig. 4E and F) . To ensure that the lack of activity against these substrates was not due to the presence of an inhibitory substance in the substrate, parallel digestions were conducted with P. aeruginosa LasB. LasB digested lactoferrin, transferrin, IgG, and IgM but not IgA (data not shown).
DISCUSSION

B. cenocepacia
ZmpA is expressed as a preproenzyme (10) . Expression of the ZmpA pro sequence appears to be necessary for the correct folding and autocatalytic processing of the ZmpA protease as has been shown previously for P. aeruginosa LasB and B. thermoproteolyticus thermolysin (32, 42) . ZmpA residues E377 and H465 were necessary for the autocatalytic activity of the preproZmpA and for proteolytic activity in B. cenocepacia. Mutagenesis of the corresponding residues in P. aeruginosa LasB, E338 (residue 141 on the mature LasB sequence), and H420 (residue 223 on the mature LasB sequence) resulted in the loss of both autoproteolytic processing (24) of the proLasB and proteolytic activity of LasB (31, 33) . Mutagenesis of the corresponding residues E375 and H463 (E143 and H231 in the mature protease) of a B. thermoproteolyticus thermolysin homologue, Bacillus subtilis neutral protease, also inactivated the enzyme (50) . Mutagenesis of a putative zincbinding ligand in ZmpA (H 380 ) also resulted in defective autocatalytic processing in E. coli. Changing H380 to either an alanine or a proline appeared to alter the structure or stability of ZmpA, since these mutant ZmpAs were not detectable in Western blots of B. cenocepacia cell extracts.
Sequence analysis suggested that ZmpA belongs to the metalloprotease clan MA, family M4 (i.e., the thermolysin-like metalloproteases) and not to the serralysins that belong to the metalloprotease clan MB, family M10 (10). Although ZmpA activity was inhibited by EDTA and 1,10-phenanthroline, it was not inhibited by the specific thermolysin inhibitor, phosphoramidon. Phosphoramidon is a peptide that mediates its inhibition by binding to the active site region of thermolysinlike proteases typified by B. thermoproteolyticus thermolysin (15, 53) . Thermolysin-like proteases that are more phylogenically related to thermolysin are sensitive to phosphoramidon. Phosphoramidon was specifically designed for thermolysin, and sequence differences in thermolysin-like proteases correlate with decreased phosphoramidon sensitivity (11) .
Previously, it has been shown that ZmpA cleaves collagen, gelatin, and hide powder azure (34) . Bacterial proteases may cause tissue damage by directly degrading host tissues. In this study, both recombinant and native ZmpAs were found to cleave the tissue components fibronectin and type IV collagen, which are also cleaved by P. aeruginosa LasB (1, 17) . Proteolytic degradation of collagen and fibronectin in the tissue matrix in the CF lung leads to loss of normal tissue morphology. Repeated cycles of bacterial infection and inflammation lead to bronchial wall thickening and bronchiectasis (reviewed in reference 47). Thus, proteases secreted by B. cenocepacia and/or P. aeruginosa may directly contribute to tissue pathology that occurs in the CF lung.
ZmpA may also contribute to virulence through the modulation of host defenses. ZmpA was found to specifically cleave ␣-1 proteinase inhibitor, which inhibits neutrophil elastase, and ␣ 2 -macroglobulin, a universal protease inhibitor. P. aeruginosa LasB, has been shown to cleave ␣-1 proteinase inhibitor specifically at P357-M358 (39), whereas ZmpA cleaves ␣-1 at T11-D12. Whether this cleavage inactivates neutrophil ␣-1 proteinase inhibitor is yet to be determined. It has been indicated that bacterial proteases, such as P. aeruginosa LasB, may play a role in host-derived damage to tissues by causing an imbalance between neutrophil elastase and the host protease inhibitors, ␣ 1 -proteinase inhibitor, and ␣ 2 -macroglobulin (38, 40) . Neutrophil elastase degrades tissue components including elastin, type III and IV collagens, and fibronectin. Without the control of ␣ 1 -proteinase inhibitor and ␣ 2 -macroglobulin, neutrophil elastase proteolysis may go unchecked, resulting in increased tissue damage. In the healthy lung, neutrophil elastase is balanced by the inhibitors ␣ 1 -proteinase inhibitor, secretory leukocyte protease inhibitor and elafin. In the cystic fibrosis lung, the balance of antiproteases is tipped towards proteases (reviewed in reference 3), resulting in tissue damage. Aerosolized ␣ 1 -proteinase inhibitor can reduce the neutrophil elastase burden in P. aeruginosa experimental infections, resulting in reduced lung inflammation (6) . Thus, ZmpA may contribute to lung pathology through the direct degradation of host tissues (e.g., collagen, fibronectin) or through modulation of host defenses (e.g., ␣-1 protease inhibitor).
Interestingly, ZmpA specifically cleaved ␣ 2 -macroglobulin, which is known as a universal protease inhibitor since it can inhibit proteases of all classes. ␣ 2 -Macroglobulin binds to and "traps" proteases, resulting in inhibition of their proteolytic activity (4). ␣ 2 -Macroglobulin has also been shown to be cleaved by a Lysobacter enzymogenes proteinase (52); however, very few bacterial proteases have been reported to cleave ␣ 2 -macroglobulin. The repercussions of possible inactivation of ␣ 2 -macroglobulin could be catastrophic to the host. Whether B. cenocepacia ZmpA can inactivate ␣ 2 -macroglobulin in vivo is currently unknown.
Bacterial metalloproteases may also contribute to pathogenesis by the ability to interrupt the immune response. ZmpA did not cleave immunoglobulins under the conditions employed; however, ZmpA was found to cleave IFN-␥, a cytokine that enhances T-cell immunity. P. aeruginosa, Serratia, and Streptococcus proteases degrade IFN-␥ (reviewed in reference 28). Degradation of IFN-␥ may allow a pathogen to establish a chronic infection, thereby aiding in the pathogenesis of the organism (20, 21) . Thus, the potential for ZmpA to contribute to pathogenesis through mechanisms other than direct host tissue proteolysis exists. This study demonstrates the importance of residues E377 and H465 in the autocatalytic and proteolytic activity of ZmpA and suggests that H380 is important for structural stability as well as autocatalytic activity. The data suggest that the active site predicted using sequence comparison to other M4 thermolysin-like metalloproteases is correct. The conservation of the active site residues and similarity to other M4 zinc metalloproteases suggest that ZmpA conducts catalysis by a mechanism similar to that of other M4 zinc metalloproteases. ZmpA can cleave a number of biologically relevant substrates, indicating that ZmpA may contribute to the pathogenesis of B. cenocepacia through the direct degradation of host tissues or through a modulation of the host immune system.
